Pharmacokinetics of Psilocybin: A Systematic Review

Pharmacokinetics of Psilocybin: A Systematic Review

<b>Background:</b> Psilocybin has shown promise in therapeutic applications for mental disorders. Understanding the pharmacokinetics of psilocybin and its active metabolite psilocin is crucial for optimizing its clinical use and minimizing adverse effects. <b>Methods:</b> Thi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, Trusha Tullu, Richard J. Zeifman, Yanbo Zhang, Lisa Burback, Olga Winkler, Andrew Greenshaw, Muhammad Ishrat Husain, Amy C. Reichelt, Eric Vermetten, Manish K. Jha, Rakesh Jetly, Raimar Loebenberg, Venkat Bhat
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Pharmaceutics
Subjects:	psilocybin pharmacokinetics metabolism CYP450
Online Access:	https://www.mdpi.com/1999-4923/17/4/411
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
by: Jacob S. Aday, et al.
Published: (2025-03-01)

Exploring the role of the psychedelic alkaloid psilocybin in alleviating cancer-related distress
by: Fejzić Dino
Published: (2025-03-01)

Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial
by: Jiwon Lee, et al.
Published: (2024-12-01)

Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters
by: Jonathan Cohen, et al.
Published: (2025-04-01)

LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice
by: Gregory Ian Robinson, et al.
Published: (2025-03-01)

Is there mush-room to improve the environmental sustainability of psilocybin production?
by: Luke Lanham, et al.
Published: (2025-08-01)

Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care
by: Michel Dorval, et al.
Published: (2025-01-01)

Refractory CRPS pain treated with psilocybin: A case report
by: David S. Jevotovsky, et al.
Published: (2024-09-01)

Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception
by: Stephanie Muller, et al.
Published: (2025-07-01)

The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review
by: Charles Palmer, et al.
Published: (2025-05-01)

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01)

Therapeutic and legal aspects of psilocybin in cancer-related depression
by: Wierzbicka Małgorzata, et al.
Published: (2025-08-01)

Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials
by: Francesco Bevione, et al.
Published: (2025-07-01)

Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models
by: Dotun Adeyinka, et al.
Published: (2025-08-01)

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01)

Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
by: Nilubon Thaoboonruang, et al.
Published: (2025-04-01)

Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa
by: Stephanie Knatz Peck, et al.
Published: (2025-05-01)

“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke
by: Patricia A. Cioe, et al.
Published: (2025-07-01)

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics
by: Martin L. Williams, et al.
Published: (2025-04-01)

The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?
by: Trevor R. Norman
Published: (2025-08-01)

Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.
by: Shakila Meshkat, et al.
Published: (2025-01-01)

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence
by: Elena Koning, et al.
Published: (2024-12-01)

Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience
by: Mourad Wahba, et al.
Published: (2024-11-01)

Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice
by: V. V. Smirnov, et al.
Published: (2018-02-01)

Effects of Psilocin and Psilocybin on Human 5-HT<sub>4</sub> Serotonin and H<sub>2</sub> Histamine Receptors in Perfused Hearts of Transgenic Mice
by: Pauline Braekow, et al.
Published: (2025-07-01)

Genome-wide identification and analysis of the cytochrome P450 family elucidate flavonoid biosynthesis in safflower
by: Yao Wu, et al.
Published: (2025-08-01)

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01)

Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report
by: John Perna, et al.
Published: (2025-02-01)

Optimizing the therapeutic benefits of synriam combined with praziquantel in mice harbouring juvenile and mature Schistosoma mansoni
by: Abdel-Nasser A. Sabra, et al.
Published: (2025-08-01)

Characterisation of the Self‐Sufficient Cytochrome P450 CYP116B234 From Rhodococcus globerulus and Its Suggested Native Role in 2‐Hydroxyphenylacetic Acid Metabolism
by: Simran Kundral, et al.
Published: (2025-03-01)

PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM
by: Ekaterina S. Kropacheva
Published: (2018-12-01)

iTRAQ-based quantitative proteomic analysis of herbicide stress in Avena ludoviciana Durieu
by: Hossein Adim, et al.
Published: (2025-01-01)

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat
by: Grace Blest-Hopley, et al.
Published: (2025-08-01)

Aspects of «Cocktail» cytochrome P450 activity determination methods application with the view of drug treatment rationalization
by: E. . Egorenkov, et al.
Published: (2020-04-01)

Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials
by: Itsuki Terao, et al.
Published: (2024-12-01)

METABOLIC ACTIVITY STUDY IN PEOPLE WITH DRUG ALLERGY USING «COCKTAIL» PHENOTYPING METHOD
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

The role of the cytochrome P450 superfamily in the skin
by: Qianqian Chen, et al.
Published: (2024-01-01)

Genome-wide identification and expression analyses of CYP450 genes in Chrysanthemum indicum
by: Yuyuan Chen, et al.
Published: (2025-05-01)

Analysis of CYP701A1 genes in gossypium species and functional characterization through gene silencing
by: Zhao Liang, et al.
Published: (2025-02-01)

OTIMIZAÇÃO DA TÉCNICA DA PCR PARA A DETECÇÃO DO POLIMORFISMO CYP3A4*1B E FREQUÊNCIA ALÉLICA ENTRE 60 MORADORES DE SÃO LUÍS/MA
by: Bruna Aparecida Penha, et al.
Published: (2013-10-01)